CB1R antagonist 1

CAS No. 334668-69-8

CB1R antagonist 1( —— )

Catalog No. M35611 CAS No. 334668-69-8

CB1R antagonist 1 is a potent CB1R antagonist that can be used to study diseases related to the nervous system.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 65 In Stock
10MG 112 In Stock
25MG 188 In Stock
50MG 272 In Stock
100MG 407 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CB1R antagonist 1
  • Note
    Research use only, not for human use.
  • Brief Description
    CB1R antagonist 1 is a potent CB1R antagonist that can be used to study diseases related to the nervous system.
  • Description
    CB1R Allosteric modulator 5, a selective cannabinoid-1 receptor (CB1R) inverse agonist with an IC50 value of 4.2 μM and EC50 value of >10 μM. CB1R Allosteric modulator 5 can be used for the research of metabolic and obesity.
  • In Vitro
    CB1R Allosteric modulator 5 has cannabinoid-1 receptor (CB1R) activity with an IC50value of 4.2 μM and EC50 value of >10 μM.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    Cannabinoid Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    334668-69-8
  • Formula Weight
    404.45
  • Molecular Formula
    C18H23F3N2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (247.25 mM; Ultrasonic )
  • SMILES
    S(=O)(=O)(C1=CC(C(F)(F)F)=CC=C1)N2CCN(C(=O)C3CCCCC3)CC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Petr Vachal, et al. 1-Sulfonyl-4-acylpiperazines as selective cannabinoid-1 receptor (CB1R) inverse agonists for the treatment of obesity. J Med Chem. 2009 Apr 23;52(8):2550-8?
molnova catalog
related products
  • Tetrahydrocannabivar...

    Tetrahydrocannabivarin is a neutral cannabis receptor subtype (CB1) receptor antagonist, it can increases neural responding to rewarding and aversive stimuli, this effect profile suggests therapeutic activity in obesity, perhaps with a lowered risk of depressive side effects. Tetrahydrocannabivarin exhibits anticonvulsant effects in a piriform cortical brain slice model of epileptiform activity.

  • AM1241

    A potent, selective cannabinoid receptor CB2 agonist with Ki of 7.1 nM.

  • Taranabant (1R,2R) s...

    A diastereomer form of Taranabant, which is a potent, selective and orally active cannabinoid-1 receptor (CB1R) inverse agonist